Lupin Quarterly Results for Trading Insights

LUPIN • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1,485 Cr
QSept 2025
Quarterly Results

Lupin Quarterly Results Key Highlights

  • Revenue of ₹6,921 Cr in Sept 2025 (+23.2% vs Mar 2025, +25.0% vs Sept 2024)
  • Net Profit of ₹1,485 Cr in Sept 2025 (+89.9% vs Mar 2025, +72.7% vs Sept 2024)
  • EBITDA of ₹2,215 Cr in Sept 2025 (+74.0% vs Mar 2025)
  • Operating Margin of 31.0% in Sept 2025 (+9.0pp vs Mar 2025)
  • Earnings Per Share of ₹32.36 in Sept 2025 (+91.1% vs Mar 2025)

Lupin Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 6,921 5,619 6,243 7,215 5,539 23.2% 25.0%
Net Profit (₹ Cr) 1,485 782 1,222 1,181 860 - -
EBITDA (₹ Cr) 2,215 1,273 1,702 1,883 1,207 - -
EPS (₹) 32.36 16.93 26.70 25.74 18.70 - -
Operating Margin (%) 31.0% 22.0% 26.0% 25.0% 21.0% - -

Lupin Share Price Trend Around Quarterly Results

Visualize Lupin's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for Lupin

Additional stock information and data for LUPIN

LUPIN stock overview
LUPIN earnings multiple
LUPIN 52-week performance

Profitability Ratios

Profit Margin 21.5%
EBITDA Margin 32.0%
Operating Margin 31.0%
ROE (Annual) 34.3%

Balance Sheet Highlights

Total Assets ₹29,205 Cr
Total Equity ₹17,294 Cr
Current Assets ₹16,799 Cr
Current Liabilities ₹2,949 Cr

Cash Flow Analysis

Operating Cash Flow ₹3,000 Cr
Investing Cash Flow ₹-4,172 Cr
Financing Cash Flow ₹1,732 Cr
Net Cash Flow ₹560 Cr

Current Market Data

Current Price ₹2294.10
Exchange NSE
Last Updated Apr 08, 2026

Revenue Trend (₹ Cr)

Dec 2025 7,215
Jun 2025 6,243
Mar 2025 5,619
Sept 2025 6,921

Net Profit Trend (₹ Cr)

Dec 2025 1,181
Jun 2025 1,222
Mar 2025 782
Sept 2025 1,485

Operating Margin Trend (%)

Dec 2025 25.0%
Jun 2025 26.0%
Mar 2025 22.0%
Sept 2025 31.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Lupin quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1714.6 14,875 3,125 +10.8% - 21.0% 131.9
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5882.0 2,860 689 +7.1% - 24.1% 226.5
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4029.2 3,219 591 +11.3% - 18.4% 229.7
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1191.4 9,135 1,337 +1.1% - 14.6% 73.6
Cipla
Sept 2025 		₹96,319.77 Cr 1215.9 7,716 1,353 +12.0% - 17.5% 72.7
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores